Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherRent ExpenseShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Cannabis Bioscience International Holdings (CBIH) EBIAT (2022 - 2026)

Cannabis Bioscience International Holdings' EBIAT history spans 5 years, with the latest figure at -$103933.0 for Q1 2026.

  • On a quarterly basis, EBIAT rose 42.66% to -$103933.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$515288.0, a 8.94% decrease, with the full-year FY2025 number at -$548820.0, up 15.74% from a year prior.
  • EBIAT hit -$103933.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from -$116966.0 in the prior quarter.
  • Over the last five years, EBIAT for CBIH hit a ceiling of -$76305.0 in Q3 2024 and a floor of -$324655.0 in Q1 2023.
  • Historically, EBIAT has averaged -$166018.2 across 5 years, with a median of -$158589.0 in 2024.
  • Biggest five-year swings in EBIAT: skyrocketed 58.03% in 2024 and later crashed 55.77% in 2025.
  • Tracing CBIH's EBIAT over 5 years: stood at -$219886.0 in 2022, then skyrocketed by 43.41% to -$124426.0 in 2023, then soared by 36.08% to -$79528.0 in 2024, then crashed by 47.08% to -$116966.0 in 2025, then increased by 11.14% to -$103933.0 in 2026.
  • Business Quant data shows EBIAT for CBIH at -$103933.0 in Q1 2026, -$116966.0 in Q4 2025, and -$82645.0 in Q3 2025.